Related Experiment Video
Updated: Jul 16, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningococcemia: epidemiology, pathophysiology, and management
1Critical Care Services, Children's Medical Center Dallas, 1935 Motor Street, Dallas, TX 75235, USA. lisa.milonovich@childrens.com
Summary
Prompt recognition and aggressive treatment are crucial for survival in pediatric meningococcemia, a severe Neisseria meningitidis infection. Ongoing research aims to improve outcomes for this devastating disease.
Area of Science:
- Pediatric Infectious Diseases
- Critical Care Medicine
- Bacteriology
Background:
- Meningococcemia, caused by Neisseria meningitidis, is a rare but severe infection primarily affecting children.
- Neisseria meningitidis exhibits high virulence, necessitating rapid diagnosis and intervention to mitigate severe outcomes.
- Managing pediatric meningococcemia in the intensive care unit presents significant challenges, demanding specialized expertise and advanced resources.
Purpose of the Study:
- To highlight the critical importance of early detection and management of meningococcemia in pediatric patients.
- To underscore the challenges associated with treating severe meningococcal infections in a pediatric intensive care setting.
- To emphasize the current limitations and future directions in meningococcemia research and therapy.
Main Methods:
- This abstract summarizes current understanding and clinical approaches to meningococcemia.
- It reviews the high virulence of Neisseria meningitidis compared to other Gram-negative bacteria.
- It discusses the essential components for managing affected children in a pediatric intensive care unit.
Main Results:
- Prompt recognition of meningococcemia signs and symptoms is vital for patient survival.
- Aggressive treatment strategies are currently the most effective approach to managing the disease.
- Despite research efforts, prompt clinical intervention remains the cornerstone of improving survival rates.
Conclusions:
- Early identification and immediate, aggressive treatment are paramount for improving survival in pediatric meningococcemia.
- While novel therapies are under investigation, current management relies heavily on prompt clinical recognition and intervention.
- The high virulence of Neisseria meningitidis underscores the need for continued research into more effective treatments to reduce morbidity and mortality.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
07:26Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Published on: July 1, 2018
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...